Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

NCT03377387 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Neratinib
BEHAVIORAL: EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]